論文・総説 - 東田　修二

分割表示  325 件中 81 - 100 件目  ／  全件表示 >>

  1. Nara N, Suzuki T, Nagata K, Tohda S, Yamashita Y, Nakamura Y, Imai Y, Morio T, Minamihisamatsu M. Granulocyte colony-stimulating factor-dependent growth of an acute myeloblastic leukemia cell line. Jpn J Cancer Res. 1990.06; 81 (6-7): 625-631. ( PubMed )

  2. Murohashi I, Tohda S, Suzuki T, Nagata K, Yamashita Y, Nara N. Mechanism of action of interleukin 1 on the progenitors of blast cells in acute myeloblastic leukemia. Exp Hematol. 1990.02; 18 (2): 133-137. ( PubMed )

  3. Nara N, Tohda S, Suzuki T, Nagata K, Yamashita Y, Imai Y, Morio T, Bessho M, Shibuya A, Adachi Y. Terminal differentiation to mature neutrophils and eosinophils in suspension culture of the blast progenitors in acute myeloblastic leukemia. Hematol Pathol. 1990; 4 (3): 125-134. ( PubMed )

  4. Nara N, Tohda S, Nagata K, Suzuki T, Yamashita Y, Imai Y. Effect of platelet-derived growth factor on the proliferation of blast progenitors from acute myeloblastic leukemia patients. Acta Haematol. 1990; 83 (4): 187-192. ( PubMed )

  5. Maruyama Y, Tohda S, Nagata K, Suzuki T, Murohashi I, Nara N. Role of humoral and cellular factors on the growth of blast progenitors of acute myeloblastic leukemia in serum-free culture. Hematol Pathol. 1990; 4 (3): 115-123. ( PubMed )

  6. Nagata K, Tohda S, Suzuki T, Nara N. Effects of recombinant human tumor necrosis factor on the self-renewal capacity of leukemia blast progenitors in acute myeloblastic leukemia. Leukemia. 1989.09; 3 (9): 626-630. ( PubMed )

  7. Nara N, Tohda S, Nagata K, Suzuki T, Yamashita Y. Inhibition of the in vitro growth of blast progenitors from acute myeloblastic leukemia patients by transforming growth factor-beta (TGF-beta). Leukemia. 1989.08; 3 (8): 572-577. ( PubMed )

  8. Murohashi I, Tohda S, Suzuki T, Nagata K, Yamashita Y, Nara N. Autocrine growth mechanisms of the progenitors of blast cells in acute myeloblastic leukemia. Blood. 1989.07; 74 (1): 35-41. ( PubMed )

  9. Murohashi I, Tohda S, Suzuki T, Nagata K, Yamashita Y, Nara N, Aoki N. Expression of interleukin 1 beta receptors on blast cells in acute myeloblastic leukemia: comparison with interleukin 1 beta proliferative activity. Cancer Res. 1989.06; 49 (12): 3431-3435. ( PubMed )

  10. Murohashi I, Tohda S, Suzuki T, Nagata K, Yamashita Y, Nara N. Specific binding of radioiodinated human GM-CSF to the blast cells of acute myeloblastic leukemia. Leuk Res. 1989; 13 (7): 599-604. ( PubMed )

  11. Yoshihiro Umezawa, Kota Yoshifuji, Keisuke Tanaka, Ayako Nogami, Katsutoshi Nagano, Ayako Tsuji, Toshikage Nagao, Masahide Yamamoto, Michiko Kajiwara, Shuji Tohda, Takehiko Mori. Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2024.05; 103 (5): 1737-1744. ( PubMed, DOI )

  12. Seiya Oba, Tadashi Hosoya, Risa Kaneshige, Daisuke Kawata, Taiki Yamaguchi, Takahiro Mitsumura, Sho Shimada, Sho Shibata, Tomoya Tateishi, Ryuji Koike, Shuji Tohda, Akihiro Hirakawa, Nukui Yoko, Yasuhiro Otomo, Junzo Nojima, Yasunari Miyazaki, Shinsuke Yasuda. Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching. Front Immunol. 2023; 14 1227547. ( PubMed, DOI )

  13. S Nogami, N Kawaguchi-Ihara, E Shiratori, M Ohtaka, M Itoh, S Tohda. Detection of the MYD88 mutation by the combination of the allele-specific PCR and quenching probe methods. Int J Lab Hematol. 2017.04; 39 (2): 163-168. ( PubMed, DOI )

  14. Shinji Ogihara, Ryoichi Saito, Etsuko Sawabe, Takahiro Kozakai, Mari Shima, Yoshibumi Aiso, Toshihide Fujie, Yoko Nukui, Ryuji Koike, Michio Hagihara, Shuji Tohda. Molecular typing of methicillin-resistant Staphylococcus aureus: Comparison of PCR-based open reading frame typing, multilocus sequence typing, and Staphylococcus protein A gene typing. J. Infect. Chemother.. 2018.04; 24 (4): 312-314. ( PubMed, DOI )

  15. Erika Shiratori, Mai Itoh, Shuji Tohda. MYD88 Inhibitor ST2825 Suppresses the Growth of Lymphoma and Leukaemia Cells. Anticancer Res.. 2017.07; 37 (11): 6203-6209. ( PubMed, DOI )

  16. Mika Ohtaka, Mai Itoh, Shuji Tohda. BMI1 Inhibitors Down-regulate NOTCH Signaling and Suppress Proliferation of Acute Leukemia Cells. Anticancer Res.. 2017.08; 37 (11): 6047-6053. ( PubMed, DOI )

  17. Miyako Murakawa, Yasuhiro Asahina, Hiroko Nagata, Mina Nakagawa, Sei Kakinuma, Sayuri Nitta, Fukiko Kawai-Kitahata, Satoshi Otani, Shun Kaneko, Masato Miyoshi, Tomoyuki Tsunoda, Yu Asano, Ayako Sato, Yasuhiro Itsui, Seishin Azuma, Toshihiko Nouchi, Yohei Furumoto, Tooru Asano, Yoshimichi Chuganji, Shuji Tohda, Mamoru Watanabe. ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin. Hepatol. Res.. 2017.10; 47 (11): 1212-1218. ( PubMed, DOI )

  18. Yuki Okuhashi, Mai Itoh, Shuji Tohda. Hedgehog Stimulation Suppresses Clonogenicity and Activates NOTCH Signalling in T-lymphoblastic Leukaemia Jurkat Cells. Anticancer Res.. 2017.05; 37 (9): 5005-5009. ( PubMed, DOI )

  19. Miyako Murakawa, Yasuhiro Asahina, Fukiko Kawai-Kitahata, Mina Nakagawa, Sayuri Nitta, Satoshi Otani, Hiroko Nagata, Shun Kaneko, Yu Asano, Tomoyuki Tsunoda, Masato Miyoshi, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Yasuhito Tanaka, Sayuki Iijima, Kaoru Tsuchiya, Namiki Izumi, Shuji Tohda, Mamoru Watanabe. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients. J. Med. Virol.. 2017.07; 89 (7): 1241-1247. ( PubMed, DOI )

  20. Salwa M Okasha, Mai Itoh, Shuji Tohda. Sirtuin 1 Activation Suppresses the Growth of T-lymphoblastic Leukemia Cells by Inhibiting NOTCH and NF-κB Pathways. Anticancer Res. 2020.06; 40 (6): 3155-3161. ( PubMed, DOI )

< 前のページ - 次のページ >

このページの先頭へ▲